Lexpos News

A collective of 20 MPs from the different political parties have signed a letter calling for urgent action to support community pharmacies. In the letter to pharmacy Minister, Dame Andrea Leadsom MP, the MPs urged the new health minister to commit to making changes for community pharmacies and patients nationwide. Community Pharmacy England coordinated the [...]

The post MPs unite in joint letter calling for urgent change in Community Pharmacy appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Isosorbide mononitrate (Isotard® 40XL) 40mg modified-release (MR) tablets Isosorbide mononitrate (Zemon® 40 XL) 40mg modified-release (MR) tablets Isosorbide mononitrate (Nyzamac® SR) 40mg modified-release (MR) capsules MSN/2024/001 Tier 2 – medium impact Date of issue: 3rd January 2024 Zemon® 40 XL tablets [...]

The post Medicine Supply Notification: Isosorbide mononitrate 40mg modified release tablets and capsules appeared first on Community Pharmacy England.

On the 20th November 2023, Kyowa Kirin International UK NewCo Ltd increased its list prices for the following Adcal-D3 products: Product Pack size Previous list price New list price from 20 November 2023 Adcal-D3 750mg/200unit caplets 112 £2.95 £3.54 Adcal-D3 Lemon chewable tablets 56 £3.65 £4.38 Adcal-D3 Lemon chewable tablets 112 £7.49 £8.99 Adcal-D3 chewable [...]

The post Adcal-D3 reimbursement prices following list price changes appeared first on Community Pharmacy England.

With New Year’s Day (1 January 2024) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 January 2024, to submit their December FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division [...]

The post Extended FP34C submission deadline for prescriptions dispensed in December 2023 appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Phosphate Sandoz® (sodium dihydrogen phosphate anhydrous 1.936g) effervescent tablets. MSN/2023/121 Tier 2 – medium impact Date of issue 22nd December 2023 Phosphate Sandoz® effervescent tablets are in limited supply until late March 2024. Unlicensed supplies of sodium acid (dihydrogen) phosphate 1mmol [...]

The post Medicine Supply Notification: Phosphate Sandoz® (sodium dihydrogen phosphate anhydrous 1.936g) effervescent tablets appeared first on Community Pharmacy England.